Nabumetone Pregnancy and Breast Feeding Warnings

Nabumetone is also known as: Relafen

Overview

Nabumetone may harm the fetus. Do not use it during the last 3 months of pregnancy. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Nabumetone while you are pregnant. It is not known if Nabumetone is found in breast milk. Do not breast-feed while you are taking Nabumetone .

Nabumetone Pregnancy Warnings

Nabumetone has been assigned to pregnancy category C by the FDA. While animal studies failed to reveal evidence of teratogenicity, evidence of post-implantation loss has been observed in rats following oral doses which produce 6-methoxy-2-naphthylacetic acid levels similar to those obtained in humans at the maximum daily dose. There are no controlled data in human pregnancy. Use late in pregnancy may result in premature closure of the ductus arteriosus and prolong labor and delivery. It should be avoided near term. Nabumetone is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

Nabumetone Lactation Warnings

There are no data on the excretion of nabumetone or its metabolites into human milk. The active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA), is excreted in the milk of lactating rats. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.